189 related articles for article (PubMed ID: 25022516)
1. [99mTc(CO)3]+ and [99mTcO2]+ radiolabeled cyclic melanotropin peptides for melanoma SPECT imaging.
Zhang X; Teixeira V; Porcal W; Cabral P; Gambini JP; Fernandez M; Gallazzi F; Quinn TP
Curr Radiopharm; 2014; 7(1):63-74. PubMed ID: 25022516
[TBL] [Abstract][Full Text] [Related]
2. 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.
Miao Y; Benwell K; Quinn TP
J Nucl Med; 2007 Jan; 48(1):73-80. PubMed ID: 17204701
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.
Yang J; Guo H; Gallazzi F; Berwick M; Padilla RS; Miao Y
Bioconjug Chem; 2009 Aug; 20(8):1634-42. PubMed ID: 19552406
[TBL] [Abstract][Full Text] [Related]
4. Substitution of Gly with Ala enhanced the melanoma uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide.
Yang J; Miao Y
Bioorg Med Chem Lett; 2012 Feb; 22(4):1541-5. PubMed ID: 22297112
[TBL] [Abstract][Full Text] [Related]
5. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
6. 203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.
Miao Y; Figueroa SD; Fisher DR; Moore HA; Testa RF; Hoffman TJ; Quinn TP
J Nucl Med; 2008 May; 49(5):823-9. PubMed ID: 18413404
[TBL] [Abstract][Full Text] [Related]
7. Dual receptor-targeting ⁹⁹mTc-labeled Arg-Gly-Asp-conjugated Alpha-Melanocyte stimulating hormone hybrid peptides for human melanoma imaging.
Xu J; Yang J; Miao Y
Nucl Med Biol; 2015 Apr; 42(4):369-74. PubMed ID: 25577037
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of new Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides for melanoma imaging.
Flook AM; Yang J; Miao Y
Mol Pharm; 2013 Sep; 10(9):3417-24. PubMed ID: 23885640
[TBL] [Abstract][Full Text] [Related]
9. Substitution of the Lys linker with the β-Ala linker dramatically decreased the renal uptake of 99mTc-labeled Arg-X-Asp-conjugated and X-Ala-Asp-conjugated α-melanocyte stimulating hormone peptides.
Flook AM; Yang J; Miao Y
J Med Chem; 2014 Nov; 57(21):9010-8. PubMed ID: 25290883
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptake.
Yang J; Hu CA; Miao Y
Amino Acids; 2015 Apr; 47(4):813-23. PubMed ID: 25557051
[TBL] [Abstract][Full Text] [Related]
11. Effects of amino acids on melanoma targeting and clearance properties of Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides.
Flook AM; Yang J; Miao Y
J Med Chem; 2013 Nov; 56(21):8793-802. PubMed ID: 24131154
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging.
Yang J; Guo H; Miao Y
Nucl Med Biol; 2010 Nov; 37(8):873-83. PubMed ID: 21055617
[TBL] [Abstract][Full Text] [Related]
13. Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.
Wei L; Zhang X; Gallazzi F; Miao Y; Jin X; Brechbiel MW; Xu H; Clifford T; Welch MJ; Lewis JS; Quinn TP
Nucl Med Biol; 2009 May; 36(4):345-54. PubMed ID: 19423001
[TBL] [Abstract][Full Text] [Related]
14. Replacement of the Lys linker with an Arg linker resulting in improved melanoma uptake and reduced renal uptake of Tc-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide.
Yang J; Guo H; Padilla RS; Berwick M; Miao Y
Bioorg Med Chem; 2010 Sep; 18(18):6695-700. PubMed ID: 20728365
[TBL] [Abstract][Full Text] [Related]
15. Structural modification on the Lys linker enhanced tumor to kidney uptake ratios of 99mTc-labeled RGD-conjugated α-MSH hybrid peptides.
Yang J; Lu J; Miao Y
Mol Pharm; 2012 May; 9(5):1418-24. PubMed ID: 22452443
[TBL] [Abstract][Full Text] [Related]
16. Novel [
Qiao Z; Xu J; Gonzalez R; Miao Y
Mol Pharm; 2020 Sep; 17(9):3581-3588. PubMed ID: 32663011
[TBL] [Abstract][Full Text] [Related]
17. Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide.
Jiang H; Kasten BB; Liu H; Qi S; Liu Y; Tian M; Barnes CL; Zhang H; Cheng Z; Benny PD
Bioconjug Chem; 2012 Nov; 23(11):2300-12. PubMed ID: 23110503
[TBL] [Abstract][Full Text] [Related]
18. Linker modification reduced the renal uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide.
Yang J; Flook AM; Feng C; Miao Y
Bioorg Med Chem Lett; 2014 Jan; 24(1):195-8. PubMed ID: 24316121
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imaging.
Guo H; Gallazzi F; Miao Y
Mol Pharm; 2013 Apr; 10(4):1400-8. PubMed ID: 23418722
[TBL] [Abstract][Full Text] [Related]
20. Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors.
Cantorias MV; Figueroa SD; Quinn TP; Lever JR; Hoffman TJ; Watkinson LD; Carmack TL; Cutler CS
Nucl Med Biol; 2009 Jul; 36(5):505-13. PubMed ID: 19520291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
